Divis Laboratories has reported results for the quarter and the year ended March 31, 2011
The company’s net profit for the fourth quarter surged by 34.41% at Rs 174.75 crore as compared to Rs 130.01 crore for the quarter ended March 31, 2010. Its total income has soared by 55.24% at Rs 490.05 crore for the quarter under review from Rs 315.67 crore in the corresponding previous quarter.
The company has registered a growth of 26.55% in its net profit for the year ended March 31, 2011 at Rs 435.57 crore as compared to Rs 344.20 crore for the year ended March 31, 2010. Its total income has increased by 40.00% at Rs 1344.04 crore for the year from Rs 959.98 crore in previous year.
On consolidated basis, the group’s net profit for the year has rose 26.13% at Rs 429.27 crore as compared to Rs 340.34 crore for the year ended March 31, 2010. Total income for the year has increased by 37.67% at 1343.60 crore as compared to Rs 975.95 crore for the previous year.
Divis Laboratories has recommended a dividend of 500% or Rs 10 per equity share of Rs 2 face value for the year ended March 31, 2011.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.40 |
| Dr. Reddys Lab | 1219.00 |
| Cipla | 1231.00 |
| Zydus Lifesciences | 932.15 |
| Lupin | 2314.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: